Goal-directed Therapy for Patients Undergoing Pancreaticoduodenectomy

Phase 4

Completed

• Conditions: Pancreatic cancer; Surgery - Other surgery; Anaesthesiology - Anaesthetics; Cancer - Pancreatic

• Registration Number: ACTRN12616000538448
• Lead Sponsor: Austin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

All patients (age > 18 years) undergoing pancreaticoduodenectomy

Exclusion Criteria

1. Age less than 18 years
2. Abnormal pre-operative coagulopathy: INR (international normalised ratio) > 1.5, platelet count < 75 x 109/l
3. Severe hepatic insufficiency (bilirubin > 30umol/L, ALP (alkaline phosphatase) >300iu/L, ALT (alanine transaminase) > 50iu/L, albumin < 25g/dL, INR > 1.5)
4. Severe renal impairment: Serum Creatinine >250ummol/L
5. American Society of Anaesthesiologists (ASA) physical status IV or V

Study & Design

• Study Type: Interventional
• Study Design: Not specified